Dinesh Srinivasan

Dinesh Srinivasan has a diverse and extensive work experience in the field of biotechnology and pharmaceuticals. Dinesh started their career at Hoffmann-La Roche as a Post-Doctoral Fellow and later became a Research Scientist, where they worked from June 2002 to January 2013. In 2013, they joined Anthera Pharmaceuticals as a Director of Translational Sciences and stayed with the company until February 2023. Dinesh then moved on to First Wave BioPharma, Inc., where they served as Vice President of Translational Research from June 2018 to February 2023. Currently, Dinesh is the VP of Clinical Development at MindMaze, The Neurotechnology Company, starting in January 2023.

Dinesh Srinivasan holds a Ph.D. in Pharmacology & Toxicology from the University of Arizona. Dinesh also obtained a mini-MBA in BioPharma Innovation from Rutgers University. Prior to that, they earned an M.Sc. in Life-Sciences (Biotechnology) from the University of Mumbai. In addition to their formal education, Dinesh has also completed certification courses such as "A Beginner's Guide to Irrational Behavior" and "Healthcare Innovation and Entrepreneurship" from Coursera in the year 2013.